GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Inventories, Raw Materials & Components

K Pharma (TSE:4896) Inventories, Raw Materials & Components : 円9 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Inventories, Raw Materials & Components?

K Pharma's inventories, raw materials & components for the quarter that ended in Mar. 2024 was 円9 Mil.

K Pharma's quarterly raw materials increased from Sep. 2023 (円9 Mil) to Dec. 2023 (円11 Mil) but then declined from Dec. 2023 (円11 Mil) to Mar. 2024 (円9 Mil).

K Pharma's annual raw materials increased from Dec. 2021 (円10 Mil) to Dec. 2022 (円10 Mil) and increased from Dec. 2022 (円10 Mil) to Dec. 2023 (円11 Mil).


K Pharma Inventories, Raw Materials & Components Historical Data

The historical data trend for K Pharma's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Inventories, Raw Materials & Components Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
9.88 10.20 10.79

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial 10.20 8.95 9.38 10.79 9.36

K Pharma Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


K Pharma (TSE:4896) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Inventories, Raw Materials & Components
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines